Raju Prasad
Fortuna: 710 972 $ al 31/07/2026
Fortuna: 710 972 $ al 31/07/2026
Raju Prasad is currently Chief Financial & Accounting Officer at CRISPR Therapeutics AG since 2023.
Formerly, Dr. Prasad was a Research Analyst at William Blair & Co. LLC from 2014 to 2023 and a Research Associate at the University of North Carolina at Chapel Hill.
Education includes an undergraduate degree from Rutgers State University of New Jersey, a graduate degree from the University of Delaware, and a doctorate from The University of North Carolina at Charlotte.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG 0,02 % | 07/08/2026 | 14.815 ( 0,02 % ) | 710 972 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director Financiero/CFO | 14/03/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2023 |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.